Annual D&A:
$2.29M+$558.00K(+32.22%)Summary
- As of today, EWTX annual D&A is $2.29 million, with the most recent change of +$558.00 thousand (+32.22%) on December 31, 2024.
- During the last 3 years, EWTX annual D&A has risen by +$2.02 million (+741.91%).
- EWTX annual D&A is now at all-time high.
Performance
EWTX Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$570.00K+$3000.00(+0.53%)Summary
- As of today, EWTX quarterly D&A is $570.00 thousand, with the most recent change of +$3000.00 (+0.53%) on September 30, 2025.
- Over the past year, EWTX quarterly D&A has dropped by -$32.00 thousand (-5.32%).
- EWTX quarterly D&A is now -9.38% below its all-time high of $629.00 thousand, reached on December 31, 2024.
Performance
EWTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$2.32M-$32.00K(-1.36%)Summary
- As of today, EWTX TTM D&A is $2.32 million, with the most recent change of -$32.00 thousand (-1.36%) on September 30, 2025.
- Over the past year, EWTX TTM D&A has increased by +$126.00 thousand (+5.74%).
- EWTX TTM D&A is now -1.36% below its all-time high of $2.35 million, reached on June 30, 2025.
Performance
EWTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EWTX Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +32.2% | -5.3% | +5.7% |
| 3Y3 Years | +741.9% | +245.4% | +342.8% |
| 5Y5 Years | +1761.8% | - | - |
EWTX Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +741.9% | -9.4% | +519.6% | -1.4% | +342.8% |
| 5Y | 5-Year | at high | +1761.8% | -9.4% | +1166.7% | -1.4% | +2629.4% |
| All-Time | All-Time | at high | +1761.8% | -9.4% | +1325.0% | -1.4% | +5700.0% |
EWTX Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $570.00K(+0.5%) | $2.32M(-1.4%) |
| Jun 2025 | - | $567.00K(+2.3%) | $2.35M(+1.4%) |
| Mar 2025 | - | $554.00K(-11.9%) | $2.32M(+1.3%) |
| Dec 2024 | $2.29M(+32.2%) | $629.00K(+4.5%) | $2.29M(+4.4%) |
| Sep 2024 | - | $602.00K(+12.7%) | $2.19M(+5.0%) |
| Jun 2024 | - | $534.00K(+1.7%) | $2.09M(+3.6%) |
| Mar 2024 | - | $525.00K(-1.5%) | $2.02M(+16.4%) |
| Dec 2023 | $1.73M(+221.9%) | $533.00K(+7.2%) | $1.73M(+34.2%) |
| Sep 2023 | - | $497.00K(+7.8%) | $1.29M(+34.6%) |
| Jun 2023 | - | $461.00K(+91.3%) | $959.00K(+47.1%) |
| Mar 2023 | - | $241.00K(+162.0%) | $652.00K(+21.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $538.00K(+97.8%) | $92.00K(-44.2%) | $538.00K(+2.7%) |
| Sep 2022 | - | $165.00K(+7.1%) | $524.00K(+23.9%) |
| Jun 2022 | - | $154.00K(+21.3%) | $423.00K(+32.2%) |
| Mar 2022 | - | $127.00K(+62.8%) | $320.00K(+17.6%) |
| Dec 2021 | $272.00K(+47.0%) | $78.00K(+21.9%) | $272.00K(+40.2%) |
| Sep 2021 | - | $64.00K(+25.5%) | $194.00K(+49.2%) |
| Jun 2021 | - | $51.00K(-35.4%) | $130.00K(+4.8%) |
| Mar 2021 | - | $79.00K(+75.6%) | $124.00K(+45.9%) |
| Dec 2020 | $185.00K(+50.4%) | - | - |
| Jun 2020 | - | $45.00K(+12.5%) | $85.00K(+112.5%) |
| Mar 2020 | - | $40.00K | $40.00K |
| Dec 2019 | $123.00K | - | - |
FAQ
- What is Edgewise Therapeutics, Inc. annual D&A?
- What is the all-time high annual D&A for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. annual D&A year-on-year change?
- What is Edgewise Therapeutics, Inc. quarterly D&A?
- What is the all-time high quarterly D&A for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Edgewise Therapeutics, Inc. TTM D&A?
- What is the all-time high TTM D&A for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. TTM D&A year-on-year change?
What is Edgewise Therapeutics, Inc. annual D&A?
The current annual D&A of EWTX is $2.29M
What is the all-time high annual D&A for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high annual D&A is $2.29M
What is Edgewise Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, EWTX annual D&A has changed by +$558.00K (+32.22%)
What is Edgewise Therapeutics, Inc. quarterly D&A?
The current quarterly D&A of EWTX is $570.00K
What is the all-time high quarterly D&A for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high quarterly D&A is $629.00K
What is Edgewise Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, EWTX quarterly D&A has changed by -$32.00K (-5.32%)
What is Edgewise Therapeutics, Inc. TTM D&A?
The current TTM D&A of EWTX is $2.32M
What is the all-time high TTM D&A for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high TTM D&A is $2.35M
What is Edgewise Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, EWTX TTM D&A has changed by +$126.00K (+5.74%)